Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Go back to Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
(NYSE: MANE) Delayed: 102.79 --0 (-0%)
Previous Close $102.79    52 Week High
Open $102.79    52 Week Low
Day High $102.79    P/E N/A 
Day Low $102.79    EPS
Volume 26